BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30666677)

  • 1. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spitz melanoma is a distinct subset of spitzoid melanoma.
    Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
    Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF and NRAS mutations in spitzoid melanocytic lesions.
    Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
    Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.
    Lott JP; Wititsuwannakul J; Lee JJ; Ariyan S; Narayan D; Kluger HH; Lazova R
    J Am Acad Dermatol; 2014 Dec; 71(6):1077-82. PubMed ID: 25308882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of activated Akt in benign nevi, Spitz nevi and melanomas.
    Kantrow SM; Boyd AS; Ellis DL; Nanney LB; Richmond A; Shyr Y; Robbins JB
    J Cutan Pathol; 2007 Aug; 34(8):593-6. PubMed ID: 17640227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of p16 in desmoplastic melanoma.
    Blokhin E; Pulitzer M; Busam KJ
    J Cutan Pathol; 2013 Sep; 40(9):796-800. PubMed ID: 23808580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
    Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K
    Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosette-like structures in the spectrum of spitzoid tumors.
    Arps DP; Harms PW; Chan MP; Fullen DR
    J Cutan Pathol; 2013 Sep; 40(9):788-95. PubMed ID: 23808731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment.
    Barnhill RL
    Mod Pathol; 2006 Feb; 19 Suppl 2():S21-33. PubMed ID: 16446713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9p21 gene locus in Spitz nevi of older individuals: absence of cytogenetic and immunohistochemical findings associated with malignancy.
    Horst BA; Terrano D; Fang Y; Silvers DN; Busam KJ
    Hum Pathol; 2013 Dec; 44(12):2822-8. PubMed ID: 24134932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
    Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
    Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
    Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.